Alvotech (ALVO)
14.40
-0.11
(-0.76%)
USD |
NASDAQ |
May 03, 16:00
14.39
-0.01
(-0.07%)
Pre-Market: 20:00
Alvotech Shareholders Equity (Quarterly): -932.49M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -932.49M |
| September 30, 2023 | -660.85M |
| June 30, 2023 | -478.54M |
| March 31, 2023 | -655.77M |
| Date | Value |
|---|---|
| December 31, 2022 | -564.42M |
| September 30, 2022 | -277.23M |
| June 30, 2022 | -296.22M |
| December 31, 2021 | -135.61M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-932.49M
Minimum
Dec 2023
-135.61M
Maximum
Dec 2021
-500.14M
Average
-521.48M
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie Inc | 8.007B |
| Teva Pharmaceutical Industries Ltd | 7.506B |
| Moolec Science SA | 6.684M |
| Procaps Group SA | 39.39M |
| NeuroMetrix Inc | 20.09M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 950.09M |
| Total Liabilities (Quarterly) | 1.883B |
| Debt to Equity Ratio | -1.030 |
| Current Ratio | 0.7467 |
| Net Debt Paydown Yield | -2.88% |